| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.2 | 6e-09 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.21 | 3e-05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0003 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |